297 related articles for article (PubMed ID: 35962436)
1. MTUS1 is a promising diagnostic and prognostic biomarker for colorectal cancer.
Cheng LY; Huang MS; Zhong HG; Ru HM; Mo SS; Wei CY; Su ZJ; Mo XW; Yan LH; Tang WZ
World J Surg Oncol; 2022 Aug; 20(1):257. PubMed ID: 35962436
[TBL] [Abstract][Full Text] [Related]
2. Colorectal cancer with low SLC35A3 is associated with immune infiltrates and poor prognosis.
Lu S; Sun X; Tang H; Yu J; Wang B; Xiao R; Qu J; Sun F; Deng Z; Li C; Yang P; Yang Z; Rao B
Sci Rep; 2024 Jan; 14(1):329. PubMed ID: 38172565
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive analysis reveals TSPEAR as a prognostic biomarker in colorectal cancer.
Xue D; Peng H; Li Z; Xu J; Ma H; Dang Y; Li F; Wang G; Sun Q
J Cancer; 2024; 15(3):809-824. PubMed ID: 38213725
[No Abstract] [Full Text] [Related]
4. Large tumor suppressor 2 is a prognostic biomarker and correlated with immune infiltrates in colorectal cancer.
Zhao C; Chen J; Liu Y; Ju S; Wang G; Wang X
Bioengineered; 2021 Dec; 12(2):11648-11661. PubMed ID: 34699318
[TBL] [Abstract][Full Text] [Related]
5. MTUS1 and its targeting miRNAs in colorectal carcinoma: significant associations.
Ozcan O; Kara M; Yumrutas O; Bozgeyik E; Bozgeyik I; Celik OI
Tumour Biol; 2016 May; 37(5):6637-45. PubMed ID: 26643896
[TBL] [Abstract][Full Text] [Related]
6. SEMA6B Overexpression Predicts Poor Prognosis and Correlates With the Tumor Immunosuppressive Microenvironment in Colorectal Cancer.
Li T; Yan Z; Wang W; Zhang R; Gan W; Lv S; Zeng Z; Hou Y; Yang M
Front Mol Biosci; 2021; 8():687319. PubMed ID: 34938771
[No Abstract] [Full Text] [Related]
7. SLC2A1 is a Diagnostic Biomarker Involved in Immune Infiltration of Colorectal Cancer and Associated With m6A Modification and ceRNA.
Liu XS; Yang JW; Zeng J; Chen XQ; Gao Y; Kui XY; Liu XY; Zhang Y; Zhang YH; Pei ZJ
Front Cell Dev Biol; 2022; 10():853596. PubMed ID: 35399515
[No Abstract] [Full Text] [Related]
8. Tumor microenvironment-related gene selenium-binding protein 1 (SELENBP1) is associated with immunotherapy efficacy and survival in colorectal cancer.
Zhu C; Wang S; Du Y; Dai Y; Huai Q; Li X; Du Y; Dai H; Yuan W; Yin S; Wang H
BMC Gastroenterol; 2022 Oct; 22(1):437. PubMed ID: 36253721
[TBL] [Abstract][Full Text] [Related]
9. Integrated Analysis of Expression and Prognostic Values of Acyl-CoA Dehydrogenase short-chain in Colorectal Cancer.
Wu Q; Yan T; Chen Y; Chang J; Jiang Y; Zhu D; Wei Y
Int J Med Sci; 2021; 18(16):3631-3643. PubMed ID: 34790035
[No Abstract] [Full Text] [Related]
10. Clinicopathological Significance of MTUS1 Expression in Patients With Renal Cell Carcinoma.
Sim J; Wi YC; Park HY; Park SY; Yoon YE; Bang S; Kim Y; Jang K; Paik SS; Shin SJ
Anticancer Res; 2020 May; 40(5):2961-2967. PubMed ID: 32366449
[TBL] [Abstract][Full Text] [Related]
11. High Expression Level of TRIP6 is Correlated with Poor Prognosis in Colorectal Cancer and Promotes Tumor Cell Proliferation and Migration.
Ren H; Su Z; Yang J; Cao J; Zhang Y; Sheng K; Guo K; Wang Y
Biochem Genet; 2024 Mar; ():. PubMed ID: 38430448
[TBL] [Abstract][Full Text] [Related]
12. Decreased E2F2 Expression Correlates with Poor Prognosis and Immune Infiltrates in Patients with Colorectal Cancer.
Shang Y; Zhang Y; Liu J; Chen L; Yang X; Zhu Z; Li D; Deng Y; Zhou Z; Lu B; Fu CG
J Cancer; 2022; 13(2):653-668. PubMed ID: 35069909
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of NOP14 is associated with improved prognosis due to immune regulation in colorectal cancer.
Lu C; Liao W; Huang Y; Huang Y; Luo Y
BMC Gastroenterol; 2022 Apr; 22(1):207. PubMed ID: 35473611
[TBL] [Abstract][Full Text] [Related]
14. Prognostic and predictive value of long non-coding RNA GAS5 and mircoRNA-221 in colorectal cancer and their effects on colorectal cancer cell proliferation, migration and invasion.
Liu L; Meng T; Yang XH; Sayim P; Lei C; Jin B; Ge L; Wang HJ
Cancer Biomark; 2018; 22(2):283-299. PubMed ID: 29630521
[TBL] [Abstract][Full Text] [Related]
15. MTUS1/ATIP3a down-regulation is associated with enhanced migration, invasion and poor prognosis in salivary adenoid cystic carcinoma.
Zhao T; Ding X; Chang B; Zhou X; Wang A
BMC Cancer; 2015 Mar; 15():203. PubMed ID: 25885343
[TBL] [Abstract][Full Text] [Related]
16. CX3CR1 Acts as a Protective Biomarker in the Tumor Microenvironment of Colorectal Cancer.
Yue Y; Zhang Q; Sun Z
Front Immunol; 2021; 12():758040. PubMed ID: 35140706
[TBL] [Abstract][Full Text] [Related]
17. SPARCL1 Is a Novel Prognostic Biomarker and Correlates with Tumor Microenvironment in Colorectal Cancer.
Zhang HP; Wu J; Liu ZF; Gao JW; Li SY
Biomed Res Int; 2022; 2022():1398268. PubMed ID: 35111844
[TBL] [Abstract][Full Text] [Related]
18. Grid2 interacting protein is a potential biomarker related to immune infiltration in colorectal cancer.
Zhao J; Quan J; Chen W; Xie X
Eur J Med Res; 2023 Nov; 28(1):511. PubMed ID: 37964339
[TBL] [Abstract][Full Text] [Related]
19. Low MTUS1 Protein Expression Is Associated with Poor Survival in Patients with Colorectal Adenocarcinoma.
Park H; Jee S; Son H; Cha H; Bang S; Ahn BK; Myung J; Paik S; Kim H
Diagnostics (Basel); 2023 Mar; 13(6):. PubMed ID: 36980447
[TBL] [Abstract][Full Text] [Related]
20. ASB6 as an Independent Prognostic Biomarker for Colorectal Cancer Progression Involves Lymphatic Invasion and Immune Infiltration.
Hu Q; Chen Y; Zhou Q; Deng S; Mu B; Tang J
J Cancer; 2024; 15(9):2712-2730. PubMed ID: 38577591
[No Abstract] [Full Text] [Related]
[Next] [New Search]
